Association of +35A/C (intron3/exon3) polymorphism in SOD1-gene with diabetic nephropathy in type 1 diabetes

Romanian Journal of Morphology and Embryology

Volumn 51, Issue 1, 2010, Pages 37-41

  Panduru, N M ^a   Cimponeriu, D ^c   Cruce, M ^b   Ion, Daniela Adriana ^d   Mota E ^b   Moţa, Maria ^b   Serafinceanu, C ^a   Chivu, Laura Ioana ^d   Panduru, Mihaela ^d   Chivu, R D ^d   Covic, A C ^e  

^a Nicolae C Paulescu National Institute for Diabetes   (Romania)

^b UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^c UNIVERSITY OF BUCHAREST   (Romania)

^d CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^e GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Diabetic nephropathy; Rs2234694; SOD1+35A C polymorphism; Type 1 diabetes

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; MALE; METHODOLOGY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ROMANIA; SINGLE NUCLEOTIDE POLYMORPHISM; COMPLICATION; KIDNEY FAILURE, CHRONIC; PROCEDURES;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; INTRONS; KIDNEY FAILURE, CHRONIC; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; ROMANIA; SUPEROXIDE DISMUTASE;

EID: 77949381743     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Forbes JM, Coughlan MT, Cooper ME, Oxidative stress as a major culprit in kidney disease in diabetes, Diabetes, 2008, 57(6):1446-1454.
2. Johansen JS, Harris AK, Rychly DJ, Ergul A, Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice, Cardiovasc Diabetol, 2005, 4(1):5.
3. Lal MA, Brismar H, Eklöf AC, Aperia A, Role of oxidative stress in advanced glycation end product-induced mesangial cell activation, Kidney Int, 2002, 61(6):2006-2014.
4. Tan AL, Forbes JM, Cooper ME, AGE, RAGE, and ROS in diabetic nephropathy, Semin Nephrol, 2007, 27(2):130-143.
5. Hammes HP, Pathophysiological mechanisms of diabetic angiopathy, J Diabetes Complications, 2003, 17(2 Suppl):16-19.
6. Nishikawa T, Araki E, Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications, Antioxid Redox Signal, 2007, 9(3):343-353.
7. Ha H, Yu MR, Choi YJ, Kitamura M, Lee HB, Role of high glucose-induced nuclear factor-kB activation in monocyte chemoattractant protein-1 expression by mesangial cells, J Am Soc Nephrol, 2002, 13(4):894-902.
8. Ayo SH, Radnik RA, Garoni JA, Glass WF 2nd, Kreisberg JI, High glucose causes an increase in extracellular matrix proteins in cultured mesangial cell, Am J Pathol, 1990, 136(6):1339-1348.
9. Bagby SP, Diabetic nephropathy and proximal tubule ROS: challenging our glomerulocentricity, Kidney Int, 2007, 71(12):1199-1202.
10. Susztak K, Raff AC, Schiffer M, Böttinger EP, Glucoseinduced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy, Diabetes, 2006, 55(1):225-233.
11. Brownlee M, Biochemistry and molecular cell biology of diabetic complications, Nature, 2001, 414(6865):813-820.
12. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M, Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, Nature, 2000, 404(6779):787-790.
13. [13] Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M, http://beta.uniprot.org/uniprot/P00441, accessed Sept. 2009.
14. Marchler-Bauer A, Anderson JB, Derbyshire MK, DeWeese-Scott C, Gonzales NR, Gwadz M, Hao L, He S, Hurwitz DI, Jackson JD, Ke Z, Krylov D, Lanczycki CJ, Liebert CA, Liu C, Lu F, Lu S, Marchler GH, Mullokandov M, Song JS, Thanki N, Yamashita RA, Yin JJ, Zhang D, Bryant SH, CDD: a conserved domain database for interactive domain family analysis, Nucleic Acids Res, 2007, 35(Database issue):D237-D240.
15. Faraci FM, Didion SP, Vascular protection: superoxide dismutase isoforms in the vessel wall, Arterioscler Thromb Vasc Biol, 2004, 24(8):1367-1373.
16. Fukai T, Galis ZS, Meng XP, Parthasarathy S, Harrison DG, Vascular expression of extracellular superoxide dismutase in atherosclerosis, J Clin Invest, 1998, 101(10):2101-2111.
17. Fujita H, Fujishima H, Chida S, Takahashi K, Qi Z, Kanetsuna Y, Breyer MD, Harris RC, Yamada Y, Takahashi T, Reduction of renal superoxide dismutase in progressive diabetic nephropathy, J Am Soc Nephrol, 2009, 20(6):1303-1313.
18. DeRubertis FR, Craven PA, Melhem MF, Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol, Metabolism, 2007, 56(9):1256-1264.
19. Seaquist ER, Goetz FC, Rich S, Barbosa J, Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy, N Engl J Med, 1989, 320(18):1161-1165.
20. Borch-Johnsen K, Nørgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH, Is diabetic nephropathy an inherited complication?, Kidney Int, 1992, 41(4):719-722.
21. Quinn M, Angelico MC, Warram JH, Krolewski AS, Familial factors determine the development of diabetic nephropathy in patients with IDDM, Diabetologia, 1996, 39(8):940-945.
22. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV, Ethnic disparities in diabetic complications in an insured population, JAMA, 2002, 287(19):2519-2527.
23. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV, http://genatlas.medecine.univ-paris5.fr/, accessed Sept. 2009.
24. Al-Kateb H, Boright AP, Mirea L, Xie X, Sutradhar R, Mowjoodi A, Bharaj B, Liu M, Bucksa JM, Arends VL, Steffes MW, Cleary PA, Sun W, Lachin JM, Thorner PS, Ho M, McKnight AJ, Maxwell AP, Savage DA, Kidd KK, Kidd JR, Speed WC, Orchard TJ, Miller RG, Sun L, Bull SB, Paterson AD; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study, Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study, Diabetes, 2008, 57(1):218-228.
25. Flekac M, Skrha J, Hilgertova J, Lacinova Z, Jarolimkova M, Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus, BMC Med Genet, 2008, 9:30.
26. Young RP, Hopkins R, Black PN, Eddy C, Wu L, Gamble GD, Mills GD, Garrett JE, Eaton TE, Rees MI, Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function, Thorax, 2006, 61(5):394-399.
27. Armitage P, Tests for linear trends in proportions and frequencies, Biometrics, 1955, 11(3):375-386.
28. Sasieni PD, From genotypes to genes: doubling the sample size, Biometrics, 1997, 53(4):1253-1261.
29. Moien-Afshari F, Ghosh S, Elmi S, Rahman MM, Sallam N, Khazaei M, Kieffer TJ, Brownsey RW, Laher I, Exercise restores endothelial function independently of weight loss or hyperglycaemic status in db/db mice, Diabetologia, 2008, 51(7):1327-1337.
30. de Moraes C, Davel AP, Rossoni LV, Antunes E, Zanesco A, Exercise training improves relaxation response and SOD-1 expression in aortic and mesenteric rings from high caloric diet-fed rats, BMC Physiol, 2008, 8:12.
31. Frank S, Zacharowski K, Wray GM, Thiemermann C, Pfeilschifter J, Identification of copper/zinc superoxide dismutase as a novel nitric oxide-regulated gene in rat glomerular mesangial cells and kidneys of endotoxemic rats, FASEB J, 1999, 13(8):869-882.
32. Pawlak K, Pawlak D, Mysliwiec M, Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease, Clin Biochem, 2005, 38(8):700-705.
33. Suys B, de Beeck LO, Rooman R, Kransfeld S, Heuten H, Goovaerts I, Vrints C, de Wolf D, Matthys D, Manuel-yKeenoy B, Impact of oxidative stress on the endothelial dysfunction of children and adolescents with type 1 diabetes mellitus: protection by superoxide dismutase?, Pediatr Res, 2007, 62(4):456-461.
34. Li Q, Sato EF, Zhu X, Inoue M, A simultaneous release of SOD1 with cytochrome c regulates mitochondria-dependent apoptosis, Mol Cell Biochem, 2009, 322(1-2):151-159.
35. Tang Z, Shou I, Wang LN, Fukui M, Tomino Y, Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats with diabetes, Nephron, 1997, 76(3):323-330.
36. Vozenin-Brotons MC, Sivan V, Gault N, Renard C, Geffrotin C, Delanian S, Lefaix JL, Martin M, Antifibrotic action of Cu/Zn SOD is mediated by TGF-beta1 repression and phenotypic reversion of myofibroblasts, Free Radic Biol Med, 2001, 30(1):30-42.
37. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G, Insulin resistance in insulin-dependent diabetic patients with microalbuminuria, Lancet, 1993, 342(8876):883-887.
38. Trevisan R, Bruttomesso D, Vedovato M, Brocco S, Pianta A, Mazzon C, Girardi C, Jori E, Semplicini A, Tiengo A, Del Prato S, Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria, Diabetes, 1998, 47(8):1347-1353.
39. Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M, Wadén J, Rönnback M, Rosengård-Bärlund M, Björkesten CG, Taskinen MR, Groop PH; FinnDiane Study Group, Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study), Diabetes Care, 2005, 28(8):2019-2024.
40. Pambianco G, Costacou T, Orchard TJ, The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience, Diabetes Care, 2007, 30(5):1248-1254.
41. Kilpatrick ES, Rigby AS, Atkin SL, Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial, Diabetes Care, 2007, 30(3):707-712.
42. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE, Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study, Kidney Int, 2002, 62(3):963-970.
43. Houstis N, Rosen ED, Lander ES, Reactive oxygen species have a causal role in multiple forms of insulin resistance, Nature, 2006, 440(7086):944-948.
44. Panduru MN, Moţa M, Moţa E, Popa SG, Dinu R, The role of adult height, perinatal and familial factors in determining the risk of diabetic kidney disease, Infomedica, 2009, 1(147):7-11.
45. Phylactos AC, Leaf AA, Costeloe K, Crawford MA, Erythrocyte cupric/zinc superoxide dismutase exhibits reduced activity in preterm and low-birthweight infants at birth, Acta Paediatr, 1995, 84(12):1421-1425.